AMPLIFY AI Powered Equity ETF $43.89 (New York symbol AIEQ) uses IBM Watson—with its machine learning, sentiment analysis and natural language processing—to select securities for the EquBot index.

The EquBot model aims to use AI to analyze data points across news, social media, industry and analyst reports, and financial statements on thousands of U.S. companies, markets and more.

The fund, launched in October 2017, has an asset base of $113.1 million and charges an MER of 0.75%.

Utilities typically struggle when interest rates are high or are increasing rapidly. The reverse is also true—they gain when rates fall. So with interest rates falling in Canada, and likely poised to fall in the U.S., the outlook for high-quality utilities is very attractive for investors seeking high dividend yields and growth prospects.

In addition, after a decade of little growth in electricity demand, U.S. power producers—or Canadian utilities with U.S. operations—are getting a huge boost from the rapid development of energy-intensive datacentres that host supercomputers used for artificial intelligence (AI).

Below we discuss two utilities-focused ETFs. The Supplement on page 89 also looks at the key characteristics of quality exchange-traded funds.

We’ve long recommended Telus as a buy for income-seeking investors. In fact, for 2025, we selected it as the #1 Income Buy for our Successful Investor newsletter. That decision was largely based on its steady cash flow and long-term commitment to twice-yearly dividend increases. For instance, the company recently announced plans to raise its annual dividend rate 3% and 8% starting 2026.


Telus’s cash flow should also continue to improve now that it has converted most of its legacy copper lines to high-speed, fibre-optic systems. At the same time, it has upgraded its wireless networks to ultrafast 5G speeds.

A: WSP Global Inc., $284.15, symbol WSP on Toronto (Shares outstanding: 130.5 million; Market cap: $37.3 billion; www.wsp.com), is a professional services consulting firm. It employs about 72,600 people, mainly engineers, technicians, scientists, environmental specialists, planners, and architects. The company is headquartered in Montreal and has over 531 offices in 50 countries.


WSP’s projects—both recently completed and ongoing—are varied. They include a two-million-square-foot Children’s hospital in Atlanta; a 1,325 megawatts offshore wind farm in Italy; a 12-storey shipping centre in Hong Kong; and National Bank’s new head office, a 40-storey office tower in downtown Montreal.

A: Kenvue Inc., $21.64, symbol KVUE on New York (Shares outstanding: 1.9 billion; Market cap: $41.6 billion; www.kenvue.com), is a consumer health company.


Kenvue is the former Consumer Health segment of Johnson & Johnson (J&J), which set it up as an independent company in November 2021. In May 2023, the new company then completed an initial public offering, with J&J selling its interest in the business.



Today, Kenvue’s portfolio of consumer health products includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID and other iconic brands. It also owns brands Aveeno, Zyrtec, and Nicorette. Together, those products resulted in sales of $15.46 billion for 2024.